Company Filing History:
Years Active: 2020-2021
Title: Yuriko Tokura: Innovator in Anticoagulant Research
Introduction
Yuriko Tokura is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of biomedical research, particularly in the development of novel anticoagulant agents. With a total of 2 patents to her name, her work has the potential to impact medical treatments significantly.
Latest Patents
Yuriko Tokura's latest patents include innovative advancements in heparan sulfate. One patent focuses on a sulfated polysaccharide that exhibits anticoagulant activity. This invention provides a polysaccharide with a repetitive structure of a disaccharide unit composed of a hexuronic acid (HexA) residue and an α-D-glucosamine (GlcN) residue, achieving a 3-O-sulfation rate of 13% or higher in GlcN residues. Another patent outlines a method for producing heparan sulfate with anticoagulant activity. This method involves partially N-deacetylating a heparosan, depolymerizing it using heparinase III, and converting the resulting low molecular weight product into heparan sulfate.
Career Highlights
Yuriko Tokura is currently employed at Ajinomoto Co., Ltd., where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science through innovative solutions.
Collaborations
Yuriko has collaborated with notable colleagues, including Kenichi Mori and Shunsuke Yamazaki, to further her research initiatives. These collaborations have enhanced the scope and impact of her work in the field.
Conclusion
Yuriko Tokura is a trailblazer in the development of anticoagulant therapies, with her patents reflecting her innovative spirit and dedication to improving healthcare. Her contributions are poised to make a lasting impact in the medical community.